Antiseizure medication linked to lower vitamin D levels
Treatment with the antiseizure medication (ASM) carbamazepine is related to a reduction in vitamin D levels, shows a recent study. The findings from the meta-analysis, published in the journal Epilepsy Research, support the use of alternative ASMs as first-line agents. Also, the researchers strongly stress considering vitamin D supplementation for patients who are prescribed carbamazepine.
There have been concerns regarding the impact of enzyme-inducing ASMs on vitamin D -- an important molecule in both inflammation and bone metabolism pathways. Though there have been studies evaluating the relationship between chronic use of carbamazepine and vitamin D levels, there is no availability of comprehensive review to inform practitioners and policymakers.
For more details, check out the link below:
Commonly Used Antiseizure Medication Tied To Lower Vitamin D Levels: Study
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.